The a-amino-3-hydroxy-5-methyl-4-isoxazole (AMP A) receptor antagonist, 2,3-dihydroxy-6-nitro-7-sul famoyl-benzo(F)quinoxaline (NBQX), offers protection to hippocampal CAl pyramidal cells after short episodes of transient cerebral ischemia, Besides CAl pyramidal cells, neurons containing somatostatin (SS) and located in the dentate hilus of the hippocampal formation are lost after cerebral ischemia, We studied the protective effects of
Disturbed glutamatergic neurotransmission is one important mechanism involved in ischemic cell death of several neuron types (Benveniste et ai., 1984; An dine et aI., 1991) . Thus, removal of the glutamatergic input to the vulnerable CAl pyramidal neurons has a protective effect (Wieloch et aI., 1985; Johansen et aI., 1986; Benveniste et aI., 1989) . Accordingly, it has been shown that glutamate antagonists at the 0' amino-3-hydroxy-5-methyl-4-isoxazole (AMP A) re ceptor have protective capabilities against ischemic neuron loss in hippocampus CAl, striatum, neocor-neurons and CA 1 pyramidal cells, After 8 min of ischemia, NBQX prevented loss of hilar SS neurons, After 10 and 12 min of ischemia, NBQX had no significant effects on loss of SS neurons in the dentate hilus. However, in all ischemic groups, NBQX significantly reduced loss of CAl pyramidal cells as compared to control rats. This neuropro tective effect decreased gradually and significantly as the time of ischemia increased. Our results support the ob servation that SS neurons in hilus are among the most ischemia-vulnerable neurons in the brain. We found that administration of NBQX in generally accepted dosages can protect the rapidly dying SS neurons in hilus from only brief episodes of ischemia. Key Words: Ischemia NBQX-Neurons-Dentate hilus-Neuroprotection. tex, and cerebellar cortex (Sheardown et aI., 1990; Nellgard and Wieloch, 1992; Balchen and Diemer, 1992; Diemer et aI., 1990 Diemer et aI., , 1992 . In contrast to the delayed ischemic cell death seen in CAl, irreversible damage (eosinophilia) of hilar neurons containing somatostatin (SS) develops rapidly (Johansen et aI., 1987) . Since it is unknown whether AMPA receptor mediated mechanisms are involved in ischemic cell death of this particular cell type, we studied the neu roprotective effects of an AMP A antagonist, 2,3dihydroxy-6-nitro-7 -sulfamoyl-benzo( F)quinoxaline (NBQX) on hilar SS neurons, and compared results with its effects on hippocampal CAl pyramidal cells.
MATERIALS AND METHODS
The experimental protocol was approved by the Danish State Animal Inspectorate. Adult male Wistar rats (350-450g) had their vertebral arteries electrocauterized (Pul sinelli and Brierley, 1979) under methohexital anesthesia (50 mg/kg i.p.). They were then fasted for 24 h with free access to water before they were reanesthetized, intubated, and ventilated with 1.2-1.6% halothane in a gas mixture of 02:N20 (vol/vol) in the scale I :2. A femoral artery was cannulated, connected with a syringe, and the following parameters measured: pH, blood gases, MABP, and plasma glucose (PG). The carotid arteries were exposed and halo thane was disconnected 2 min before the carotids were ligated for 8, 10, or 12 min, during hypotension established by withdrawing blood (Benveniste et aI., 1989) . Rectal and scalp (temporal muscle) temperatures were monitored and both regulated by heating lamps. Ischemia was terminated by removing the carotid ligatures and reinfusing the with drawn blood, supplemented with 1-2 ml saline, until MABP of > 100 mm Hg was reached. Both rectal and scalp temperatures were controlled (setting 37°C) during the first hour after ischemia before the animals were moved to their normal 22°C stable facilities in cages. Nonischemic sham operated control rats were injected three times (0, 10, and 25 min) with 1 ml isotonic glucose i.p. (vehicle) or 30 mg/ kg of NBQX (NOVO Nordisk CNS Division, MaJ0v, Den mark) dissolved in isotonic glucose. Ischemic rats were injected i.p. with vehicle or NBQX (30 mg/kg) three times (0, 10, and 25 min) after the carotid ligatures were released.
All rats were killed via deep halothane anesthesia by perfusion fixation with 4% paraformaldehyde in 0.15 M phosphate buffer at 7 days after the ischemia or sham operation. Brains were removed from the skulls and subse quently postfixed for 4 h in the same fixative. Then, 50 fLm thick coronal sections of the dorsal hippocampus, between 2.4 and 2.6 mm caudally from the bregma, were cut on a Lancer-1000 vibratome (Technical Products International, St. Louis, MO, U.S.A.) and immunocytochemically stained according to previously described standard procedures (Jo hansen et aI., 1987) . We used SS antibodies (diluted 1 :1,000) raised against sequence 5-10 of SS-14 (Prof. 1.1. Holst, Department of Medical Physiology, University of Copen hagen). Immunosections were counterstained with hema toxylin and eosin (H&E). SS immunopositive neurons were counted in the dentate hilus at 250x magnification by light microscopy. Results were calculated per 480 fLm grid length of the dentate granule cell layer. The remaining part of the brains were embedded in paraffin for subsequent H&E staining. Coronal sections, 10 fLm thick, were cut and col lected from 2.7 mm behind bregma and more caudally. Finally, CAl pyramidal cells were counted in the light microscope per 300 fLm grid length placed in the medial, intermediate, and lateral parts of the CAl stratum pyrami dale of the ipsi-and contralateral dorsal hippocampus at 2.70-2.75 mm caudally from the bregma.
Histologic values from rats who received vehicle were com pared to NBQX-treated rats by Mann-Whitney statistics.
Comparisons of vehicle versus vehicle treatment or NBQX versus NBQX treatment between groups with different isch emic insults (i.e., controls, 8, 10, or 12 min) were performed with the Kruskal-Wallis one-way analysis of variance (ANOVA) by ranks. Comparisons performed are indicated in Fig. 1 . Statistical significance was accepted for p < 0.05. Table 1 . These were examined qualitatively and no substantial differences were observed.
RESULTS

Physiologic values are listed in
SS neurons in control and ischemic animals
Systemic NBQX administration in control animals without ischemia had no influence on morphology J Cereb Blood Flow Metab, Vol. 17, No.2, 1997 ( Fig. 2A ) as compared to control animals injected with vehicle. Cell counts in these two groups showed no statistical differences in numbers of SS neurons in the dentate hilus ( Fig. 1A) .
In rats injected with vehicle and subjected to 8,10, or 12 min of ischemia, there was a significant loss of SS neurons in hilus, as compared to vehicle-injected rats without ischemia ( Fig. lA) .
After 8 min of ischemia, NBQX prevented loss of SS neurons in hilus (Figs. 2C, 1A), but after 10 and 12 min of ischemia, NBQX had no significant effects on the loss of SS neurons in hilus (Figs. 2B, 1A).
CAl pyramidal cells in control and ischemic animals
Control rats who received either vehicle or NBQX showed no signs of neuropathological changes, e.g., eosinophilic neurons were not seen, and cell counts of CAl pyramidal cells showed no significant differ ences in numbers between these groups (Fig. IB) .
In ischemic rats treated with vehicle, CAl pyrami dal cell loss was 75-90%, but statistical analysis (Fig. lB) showed no significant differences between loss in the three groups. Loss of pyramidal cells were seen throughout CAl to the very border of CA3.
In ischemic rats treated with NBQX, CAl cell counts and statistical analysis in rats subjected to 8 and 10 min of ischemia demonstrated total protection when compared to NBQX-injected control rats ( Fig.  IB) , although a very small number of eosinophilic neurons could be observed in ischemic animals. Moreover, there was only partial protection against CA 1 pyramidal cell loss in rats subjected to 12 min of ischemia ( Fig. IB) . Also, statistical analysis showed a significant difference between loss in rats subjected to ischemia of 8 and 10 min, and 10 and 12 min, respectively ( Fig. IB) . Again, eosinophilic neurons could be seen in all three groups. Ischemic damage to the CAl pyramidal cells after NBQX treatment was randomly scattered throughout the entire CAL
DISCUSSION
We have investigated the neuroprotective effects of NBQX administered systemically during the im mediate reflow period «25 min) after 8, 10, or 12 min of cerebral ischemia. Two types of vulnerable neurons in the rat hippocampal formation were stud ied: hilar neurons containing SS and CAl pyramidal cells. After 8, but not after 10 or 12 min of ischemia, NBQX prevented loss of hilar SS neurons. In agree ment with previous reports (Sheardown et aI., 1990; Nellgard and Wieloch, 1992; Diemer et aI., 1990 Diemer et aI., , 1992 , we found that NBQX ameliorated ischemic damage to CAl pyramidal cells in all ischemic groups. A: Median number and ranges of neurons containing SS counted in the dentate hilus in control and ischemic rats 7 days after they were injected with NBQX or isotonic glucose (vehicle). Mann-Whitney and Kruskal-Wallis nonparametric statistics were applied and significance accepted for p < 0.05. Analysis showed a significant loss of SS-containing neurons in all ischemic rats injected with vehicle (a:c, a:e, a:g), but no differences between loss in the ischemic groups (c:e, c:g, e:g). NBQX prevented loss of SS-containing neurons in rats with 8 min of ischemia (b:d), and the number of SS neurons surviving the insult was accordingly significantly increased (c:d). However, �BQX did not prevent loss of SS-containing neurons in rats subjected to 10 (b:f, e:f) or 12 min (b:h, g:h) of ischemia.
There was no significant differences between cell counts in control rats injected with vehicle or NBQX (a:b). B: Median number and ranges of pyramidal cells counted in CA 1 of the hippocampal formation in control and ischemic rats 7 days after they were injected with NBQX or vehicle. Mann-Whitney and Kruskal-Wallis nonparametric statistics were applied and significance accepted for p < 0.05.
Analysis showed a significant loss of pyramidal cells in all ischemic rats injected with vehicle (a:c, a:e, a:g), but no differences between loss in the ischemic groups (c:e, c:g, e:g). NBQX prevented loss of pyramidal cells in rats with 8 (b:d) and 10 min of ischemia (b:f); and significantly increased the number of neurons surviving 12 min of ischemia (g:h). Statistical analysis suggests (d:f and f:h p < 0.05) that the neuroprotective effect decreased gradually as the time of ischemia increased. There was no significant difference between cell counts in control rats injected with vehicle and NBQX (a:b)
The CA 1 neuroprotective effect decreased gradually as the time of ischemia increased. We previously demonstrated that hilar SS neurons are lost within the first 2 days after ischemia (Jo hansen et aI., 1987 (Jo hansen et aI., , 1993 . We called this rapid ischemic cell death in contrast to the 3-4 days delayed ischemic pyramidal cell death seen in CAl and because eosinophilic neurons in hilus can be seen as early as 3 h after ischemia (Johansen, unpublished data) . Furthermore, we observed that very short episodes of ischemia damages hilar neu rons without any damage to the CAl pyramidal cells. This is in agreement with findings by Matsu yam a et al. (1993) , who concluded that hilar SS neurons are more vulnerable to ischemia than are CAl pyramidal cells. Indeed, ischemic damage to hilar neurons has been described (Ito et aI., 1975) . Recently, it has been suggested that far more neuron types than just SS neurons and mossy cells in hilus are damaged (Hsu and Buzsaki, 1993) . We cannot directly compare our results with those of the latter study, but in SS immunosections counterstained with acid fuchsin (which marks ischemic eosinophilia), eosinophilic neurons without SS immunostaining were few in number.
The nature of the SS neurons in the dentate hilus is controversial. Kosaka et al. (1988) found a high degree of neuronal colocalization of SS and gluta mate decarboxylase in hilus, whereas Sloviter and Nilaver (1987) concluded that hilar SS neurons be long to a neuron population not containing y aminobutyric acid (GABA). The latter view is indi rectly supported by several observations. Using an epilepsy model, Sloviter (1991) studied electrophysi ology in the dentate gyrus and found decreased recur rent granule cell inhibition associated with loss of hilar SS neurons and mossy cells, whereas GABA interneurons survived. On the other hand, electro physiological recordings after ischemia have demon strated increased recurrent granule cell inhibition in the dentate gyrus (Chang et aI., 1989) . Accordingly, we (Johansen et aI., 1987 (Johansen et aI., , 1989b found ischemic loss 8 min.lSC (n = 5) 8 min.lSC NBQX (n = 6) 10 min.lSC (n = 8) 10 min.lSC NBQX (n = 11) 12 min.lSC (n = 5) 12 min.lSC NBQX (n = 4) Oata are presented as means:+: SO. MABP, mean arterial blood pressure before (Pre), during (Our), and after (Post) ischemia; temperature at the beginning (Beg), half-way m, and end (End) of ischemia; PG, plasma glucose; ISC, ischemia.
of the same neuron types as in epilepsy as well as survival of the GABA interneurons (Johansen et al., 1989a) . However, in ischemia, mossy cells are lost only following prolonged insults (>30 min) (Jo hansen, unpublished data).
Both in experimental epilepsy (Sloviter, 1991) and ischemia SS neurons are lost, whereas GABA interneurons survive the insult. This suggests thqt hilar SS neurons do not contain GABA. Therefore, hilar SS neurons may be excitatory neu rons. This is supported by the observation that AMP A binding increases postischemia in the outer , molecular layer of the dentate gyrus , which is deprived of axons after ischemic loss of hilar SS neurons (Bakst et al., 1986 ). If we consider that the SS neurons in hilus reinforce granule cell excitation through feedback excitation, then in creased recurrent granule cell inhibition after isch emia (Chang et al., 1989 ) may simply follow loss of SS neurons and their feedback excitation.
Increases in intracellular calcium concentrations is suggested to play a key role in processes leading to ischemic cell death (Siesj6, 1981 (Siesj6, , 1988 Siesj6 and Bengtsson, 1989) . The AMPA receptor medi-B FIG. 2. A: Neurons containing SS are seen in an immunocyto chemically stained section from the dentate hilus of a control rat injected with NSOX. B: Same area and staining as seen in (A), but this time taken from a rat 7 days after it was subjected to 10 min of ischemia and injected with NSOX. Note severe loss of SS containing neurons C: Same area and staining as seen in (A), but this time taken from a rat 7 days after it was subjected to 8 min of ischemia and injected with NSOX. Note survival of SS containing neurons. Original magnification x 1 00. ates fast excitatory transmiSSIOn by increasing so dium and potassium ion fluxes (Verdoorn et a!., 1991) and, thereby, stimulating calcium influx through activation of voltage-dependent calcium channels. After ischemia, stimulation of the AMP A receptor may result in an increased influx of calcium from the extracellular space. The AMP A receptor in itself may be or become permeable to calcium (Sommer et a!., 1991) and/or ischemia may potenti ate processes f opening voltage-operated calcium channels in the cells. Stimulation of at least one type of metabotropic glutamate receptor can activate inositol triphosphate (Masu et a!., 1991) , thereby releasing intracellular stores of calcium. Ischemia may potentiate such receptor-coupled processes and mediate increased release of calcium from intracel lular stores in vulnerable cells. Furthermore, stimu lation of the metabotropic glutamate receptor in concert with the AMP A receptor causes release of arachidonate (Dumuis et a!., 1990) , which will potentiate NMDA receptor currents and amplify increases in the intracellular calcium concentrations caused by glutamate (Miller et a!., 1992) . It is also possible that during and/or after ischemia, vulnerable cells are less capable of handling increased (Andine et aI., 1991) or even normal influxes of ions, especially divalent cations like calcium and zinc. In this connection, we speculate (Johansen et aI., 1993) that hi lar SS neurons may be very vulnerable to ischemia since they are surrounded by the zinc-rich mossy fiber boutons from which zinc, together with glutamate, is released during synaptic transmission (Charton et aI., 1985) .
Physiological variables
Besides increase in intracellular cation levels, isch emic damage through receptor-operated mechanisms may involve changed activities of protein kinase C, phos pholipase A2, arachidonate, and production of free radi cals (Siesjo, 1981) . Recently, it was suggested that isch emic disturbances in AMP A receptor activation might lead to detrimental changes in gene expression (Zafra et aI., 1990) . Whatever the ischemic process involves, it is likely to terminate with crucial increases in intracellular calcium concentrations leading to cell death in vulnera ble neurons (Siesjo and Bengtsson, 1989) .
A large number of studies, including those on de afferentation and pharmacological treatment, have permitted the conclusion that at least some forms of regional ischemic brain injury are convincingly me diated by excitotoxic mechanisms and altered cal cium homeostasis. Lately, interest has been focused on the sedative and hypothermic effects of pharma cological treatment of ischemic brain damage. It has been demonstrated that brain temperatures at 30-33°C during and/or after ischemia confer partial pro tection against brain damage. Ginsberg and coworkers (1993) have pointed out, in their review, that the first hour of postischemic recirculation is of particular criti cal importance in hypothermic protection of ischemic damage. For example, hypothermia reduces gluta mate transmitter release, and the enzyme calcium/ calmodulin-dependent protein kinase II, which is re sponsible for signal transduction linking intracellular increases in free calcium ion to regulation of protein phosphorylation, is inhibited by normothermic isch emia, but unaffected following hypothermic ischemia.
In our study, we kept the animals normothermic during the first postischemic hour and then trans ferred them in cages to their normal environment at room temperature (22°C).
The dosages of NBQX used kept the animals hypo active for the first 3-4 h postischemia, but ischemic rats without NBQX treatment were also hypoactive in this period. Thus, examination of the significance of postischemic temperature changes in the period preceding cell death is now being carried out. In future studies, definitions of ischemic models may include long-term postischemic regulation of brain temperature. Thus, careful long-term regulation of brain temperature will further define the patho-mechanisms with which one is dealing in pharmaco logical treatment of ischemic brain damage. We sug gest that our NBQX treatment of ischemic damage in hippocampus primarily protected hilar SS neurons through mechanisms blocking glutamatergic neuro transmission immediately after ischemia. At the pres ent time, we cannot exclude that synergistic protec tive effects could have been due to the influence of NBQX on brain temperatures after the first post ischemic hour. From our study, we conclude that NBQX can protect SS neurons in the hilus from brief episodes of transient cerebral ischemia.
